Last reviewed · How we verify
Ferrotrat — Competitive Intelligence Brief
unknown
ferrous tartrate
Hematology
Live · refreshed every 30 min
Target snapshot
Ferrotrat (ferrous tartrate). Ferrotrat works by donating iron to the body, which is essential for the production of hemoglobin and the prevention of iron deficiency anemia.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Ferrotrat TARGET | ferrous tartrate | unknown | ferrous tartrate |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (ferrous tartrate class)
- · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Ferrotrat CI watch — RSS
- Ferrotrat CI watch — Atom
- Ferrotrat CI watch — JSON
- Ferrotrat alone — RSS
- Whole ferrous tartrate class — RSS
Cite this brief
Drug Landscape (2026). Ferrotrat — Competitive Intelligence Brief. https://druglandscape.com/ci/ferrous-tartrate. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing